These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23077121)

  • 1. False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci.
    Palavecino EL; Burnell JM
    J Clin Microbiol; 2013 Jan; 51(1):281-3. PubMed ID: 23077121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluation of commercial susceptibility testing methods for determining the in vitro activity of daptomycin versus Staphylococcus aureus and Enterococci.
    Kirn TJ; Onyeaso E; Syed M; Weinstein MP
    J Clin Microbiol; 2014 Jun; 52(6):1877-82. PubMed ID: 24648560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of enterococci to daptomycin is dependent upon testing methodology.
    Bryant KA; Roberts AL; Rupp ME; Anderson JR; Lyden ER; Fey PD; Van Schooneveld TC
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):497-501. PubMed ID: 23719086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2004 May; 53(5):860-2. PubMed ID: 15056637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests.
    Campeau SA; Schuetz AN; Kohner P; Arias CA; Hemarajata P; Bard JD; Humphries RM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus.
    Friedrich L; Thorne G; Steenbergen JN; Anastasiou D; Koeth L
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):306-11. PubMed ID: 19762196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab prediffusion method.
    Katz BD; Luperchio SA; Thorne GM
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):315-20. PubMed ID: 18339508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
    J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.
    Jevitt LA; Thorne GM; Traczewski MM; Jones RN; McGowan JE; Tenover FC; Brown SD
    J Clin Microbiol; 2006 Sep; 44(9):3098-104. PubMed ID: 16954233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo daptomycin-nonsusceptible enterococcal infections.
    Kelesidis T; Humphries R; Uslan DZ; Pegues D
    Emerg Infect Dis; 2012 Apr; 18(4):674-6. PubMed ID: 22469288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
    Dhawan B; Gadepalli R; Kapil A
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH; Crawford SA
    J Clin Microbiol; 2006 Jun; 44(6):2126-9. PubMed ID: 16757608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Tedizolid against Enterococci and Staphylococci, Including
    Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid.
    Riedel S; Neoh KM; Eisinger SW; Dam LM; Tekle T; Carroll KC
    J Clin Microbiol; 2014 Jun; 52(6):2216-22. PubMed ID: 24719445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
    Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
    Int J Antimicrob Agents; 2004 Jul; 24(1):59-66. PubMed ID: 15225863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.